DBV Technologies (DBVT) Total Non-Current Liabilities (2015 - 2026)

DBV Technologies (DBVT) reported Total Non-Current Liabilities of $6.7 million for Q1 2026, down 8.28% year-over-year from $7.3 million in Q1 2025, and down 2.9% quarter-over-quarter from $6.9 million in Q4 2025.

DBV Technologies (DBVT) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 12 years of Total Non-Current Liabilities data on file, last reported at $6.7 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $6.7 million, down 8.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 million (down 8.28% YoY), and the FY2025 annual result was $6.9 million, down 3.29% from the prior year.
  • Total Non-Current Liabilities slipped to $6.7 million in Q1 2026 per DBVT's latest filing, from $6.9 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $22.5 million in Q4 2022 and troughed at $5.5 million in Q4 2023.
  • A 5-year average of $10.5 million and a median of $7.8 million in 2025 frame the typical range for Total Non-Current Liabilities.
  • On a YoY basis, Total Non-Current Liabilities climbed as much as 121.92% in 2023 and fell as far as 75.78% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $22.5 million in 2022, then plunged by 75.78% to $5.5 million in 2023, then surged by 30.65% to $7.1 million in 2024, then slipped by 3.29% to $6.9 million in 2025, then slipped by 2.9% to $6.7 million in 2026.
  • Business Quant data shows DBVT's Total Non-Current Liabilities at $6.7 million in Q1 2026, $6.9 million in Q4 2025, and $8.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn 6.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.70 Mn
Dec 31, 2025 6.90 Mn
Sep 30, 2025 8.16 Mn
Jun 30, 2025 7.78 Mn
Mar 31, 2025 7.31 Mn
Dec 31, 2024 7.14 Mn
Sep 30, 2024 8.11 Mn
Jun 30, 2024 7.71 Mn
Mar 31, 2024 7.76 Mn
Dec 31, 2023 5.46 Mn
Sep 30, 2023 14.35 Mn
Jun 30, 2023 19.91 Mn
Mar 31, 2023 21.06 Mn
Dec 31, 2022 22.54 Mn
Sep 30, 2022 7.67 Mn
Jun 30, 2022 10.13 Mn
Mar 31, 2022 9.49 Mn
Dec 31, 2021 16.05 Mn
Sep 30, 2021 20.22 Mn
Jun 30, 2021 18.87 Mn